Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-21 Option Award |
2022-05-23 4:13 pm |
N/A 2032-05-21 |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
23,704 | $0 | 23,704 (Direct) |
View |
| 2022-05-21 Option Award |
2022-05-23 4:12 pm |
N/A 2032-05-21 |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
23,704 | $0 | 23,704 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:22 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
4,024 | $0 | 31,030 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:18 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
4,024 | $0 | 149,721 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Palantoni Frank Director |
4,024 | $0 | 31,030 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:16 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | NIES ALAN S Director |
4,024 | $0 | 31,744 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:15 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director |
4,024 | $0 | 31,030 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:14 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
4,024 | $0 | 4,652,759 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:12 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
4,024 | $0 | 70,315 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:11 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
4,024 | $0 | 31,030 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:18 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
11,300 | $0 | 27,763 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:18 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
3,337 | $2.85 | 27,763 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
30,128 | $0 | 47,273 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
8,261 | $2.85 | 47,273 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:16 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
54,650 | $0 | 216,842 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:16 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
19,756 | $2.85 | 216,842 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:15 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
36,628 | $0 | 118,273 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:15 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
13,241 | $2.85 | 118,273 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:13 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. |
40,880 | $0 | 137,988 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:13 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. |
15,059 | $2.85 | 137,988 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:12 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO |
66,933 | $0 | 246,500 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:12 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO |
25,773 | $2.85 | 246,500 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:11 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
197,343 | $0 | 737,300 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:11 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
48,053 | $2.85 | 737,300 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:11 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy VP, Human Resources |
227,330 | $0 | 227,330 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:10 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
307,990 | $0 | 307,990 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:09 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
275,560 | $0 | 275,560 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:08 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO |
447,290 | $0 | 447,290 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:06 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
330,680 | $0 | 330,680 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:05 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer |
1,096,370 | $0 | 1,096,370 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:04 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer |
335,000 | $0 | 335,000 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:03 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. |
313,160 | $0 | 313,160 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:02 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
79,630 | $0 | 79,630 (Direct) |
View |
| 2021-04-14 Ownership |
2022-02-11 5:27 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO |
4,500 | $0 | 152,520 (Direct) |
View |
| 2021-07-01 Ownership |
2022-01-10 4:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
5,700 | $0 | 145,697 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 9:34 pm |
N/A 2032-01-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy VP, Human Resources |
85,185 | $0 | 85,185 (Direct) |
View |
Ownership |
2021-10-29 4:18 pm |
N/A 2025-02-05 |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
0 | $0 | 241,082 (Direct) |
View |
Ownership |
2021-10-01 4:05 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
0 | $0 | 409,675 (Direct) |
View |
Ownership |
2021-09-27 4:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
0 | $0 | 58,884 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-03 4:39 pm |
N/A 2031-08-02 |
LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:07 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Palantoni Frank Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:05 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:04 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | NIES ALAN S Director |
10,499 | $0 | 10,499 (Direct) |
View |